Drug Discovery Technologies Market - Global Forecast 2026-2032

The drug discovery technologies market is transforming the pharmaceutical and biotechnology industries, introducing advanced computational tools and laboratory automation that enable organizations to optimize R&D processes and strengthen innovation pipelines. Senior decision-makers are increasingly adopting integrated approaches to match the demands of a complex, evolving ecosystem.

Market Snapshot: Drug Discovery Technologies Market

The Drug Discovery Technologies Market grew from USD 70.19 billion in 2025 to USD 77.59 billion in 2026 and is projected to reach USD 145.80 billion by 2032, reflecting a CAGR of 11.00%. This sustained growth underlines a rising dependence on computational modeling, laboratory automation, and comprehensive discovery platforms across both established pharmaceutical firms and agile biotechnology enterprises. Increasing investments in translational programs are expanding the demand for advanced biologics, targeted screening tools, and scalable analytics. As organizations navigate evolving regulatory frameworks and supply chain challenges, there is heightened emphasis on resilient procurement strategies and robust supply chain adaptability to support ongoing research objectives and operational continuity.

Scope & Segmentation

Drug Types: Biologics and small-molecule initiatives diversify organizational portfolios, directly influencing assay selection, adoption of new platforms, and workflow validation—particularly as R&D goals shift from one institution to another.
Assay Choices: A transition is underway toward integrated cell-based and reporter gene assays, while biochemical and binding assays retain importance for select target modalities and specific discovery requirements.
Platforms & Technologies: Computational modeling, high-throughput screening, pharmacogenomics, and nanotechnology tools now enable senior R&D leaders to identify promising candidates faster and minimize technical uncertainties.
Applications: Platforms in this sector support a wide array of activities including biomarker identification, lead optimization, preclinical development, target validation, and toxicology assessment—streamlining overall R&D progress and decision-making across teams.
End Users: Academic institutions, biotechnology startups, and large pharmaceutical companies apply discovery technologies with varying focuses on flexibility, speed to validation, regulatory alignment, and long-term supply chain efficiency.
Regions: The market is segmented into the Americas, Europe, Middle East & Africa, and Asia-Pacific, each exhibiting distinct dynamics in talent sourcing, regulatory compliance, procurement, and rate of adopting technological advancements within their respective drug discovery ecosystems.

Key Takeaways: Strategic Insights for Senior Decision-Makers

The convergence of computational approaches and advanced assay solutions accelerates candidate identification and enhances the predictive accuracy of drug development programs within complex pipelines.
Strategic collaboration between informatics and translational research teams is pivotal, ensuring new technologies are smoothly integrated into established discovery workflows.
Next-generation assay systems emphasize physiological relevance, as more organizations transition to multicellular and reporter-based evaluation modes to optimize data quality and reduce late-stage project attrition.
Innovation centers worldwide are refining technology adoption strategies, accounting for local regulatory standards, available expertise, and infrastructure to establish varied operational models.
Diverse end-users—spanning academia, biotech, and pharmaceutical segments—tailor their adoption of discovery platforms to balance rapid validation needs, regulatory obligations, and supplier partnerships, driving differentiated operational outcomes.

Tariff Impact: Evolving Procurement and Supply Chain Strategies

Recent adjustments in tariffs are prompting organizations to reassess global sourcing protocols and broaden their supplier networks. Procurement teams are prioritizing resilience in their vendor selection, optimizing purchasing cycles, and advancing the qualification of suppliers located closer to operations. Adoption of cloud-based and virtualized solutions is increasing, reducing reliance on physical inventories and enhancing flexibility. Strategic initiatives are focused on managing overall cost, tightening lead time, and protecting continuity of supply for essential reagents and instruments.

Methodology & Data Sources

This analysis is grounded in qualitative expert interviews, a thorough review of secondary publications, and validation through triangulation with peer-reviewed research and regulatory data. Specialists in biology, assay development, computational chemistry, and procurement contributed to the rigorous vetting process, ensuring actionable, industry-relevant insights for decision-makers.

Why This Report Matters

Enables senior leadership to align R&D investment with shifts in technology, evolving regulations, and supply chain environments—strengthening long-term organizational competitiveness.
Supports evidence-driven vendor selection, targeted risk management, and operational planning with granular segmentation and leading industry practices.
Equips leaders to accelerate program milestones and foster resilience in dynamic, compliance-focused research and development settings.

Conclusion

Leveraging this report empowers senior executives to drive innovation, validate strategic supplier relationships, and advance operational excellence. In a rapidly evolving drug discovery landscape, informed planning remains essential for sustaining competitive advantage.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Drug Discovery Technologies Market, by Drug Type

8.1. Biologic Drugs
8.2. Small-Molecule Drugs

9. Drug Discovery Technologies Market, by Assay Techniques

9.1. Binding Assays
9.2. Biochemical Assays
9.3. Cell Based Assays
9.4. Reporter Gene Assays

10. Drug Discovery Technologies Market, by Technology Platforms

10.1. Computational Modeling
10.2. High Throughput Screening
10.3. Nanotechnology
10.4. Pharmacogenomics
10.5. Structure Based Design

11. Drug Discovery Technologies Market, by Application

11.1. Biomarker Discovery
11.2. Lead Discovery
11.3. Preclinical & Clinical Development
11.4. Target Identification & Validation
11.5. Toxicology Testing

12. Drug Discovery Technologies Market, by End User

12.1. Academic Institutions
12.2. Biotechnology Firms
12.3. Pharmaceutical Companies

13. Drug Discovery Technologies Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Drug Discovery Technologies Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Drug Discovery Technologies Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Drug Discovery Technologies Market
17. China Drug Discovery Technologies Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories, Inc.
18.6. Amgen Inc.
18.7. AstraZeneca PLC
18.8. Bayer Healthcare AG
18.9. Bio-Rad Laboratories, Inc.
18.10. bioMérieux SA
18.11. Bristol-Myers Squibb Company
18.12. Covaris, LLC
18.13. Curia Global, Inc.
18.14. Elucidata Corporation
18.15. Eurofins Advinus Private Limited
18.16. Evotec SE
18.17. F. Hoffmann-La Roche Ltd.
18.18. GE Healthcare Ltd.
18.19. Gilead Sciences, Inc.
18.20. Horiba, Ltd.
18.21. Illumina, Inc.
18.22. IQVIA Inc.
18.23. Luminex Corporation by DiaSorin Group
18.24. Merck & Co., Inc.
18.25. Novartis AG
18.26. Pfizer Inc.
18.27. PIRAMAL PHARMA LIMITED
18.28. Randox Laboratories Ltd.
18.29. Revolution Medicines, Inc.
18.30. Sanofi S.A.
18.31. Sygnature Discovery Limited
18.32. Syngene International Limited
18.33. Thermo FIsher Scientific Inc.
18.34. VWR International LLC
18.35. WuXi AppTec Co., Ltd.

List of Figures

FIGURE 1. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOLOGIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BINDING ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BINDING ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BINDING ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY CELL BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY CELL BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REPORTER GENE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REPORTER GENE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REPORTER GENE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMPUTATIONAL MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMPUTATIONAL MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMPUTATIONAL MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY LEAD DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY LEAD DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PRECLINICAL & CLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PRECLINICAL & CLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PRECLINICAL & CLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 91. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 92. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 93. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 103. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 104. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 105. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 116. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 117. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 118. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. ASEAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 122. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 123. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 124. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. GCC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 134. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 135. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 136. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. BRICS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 140. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 141. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 142. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. G7 DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 146. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 147. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 148. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. NATO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 158. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 159. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY ASSAY TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 160. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORMS, 2018-2032 (USD MILLION)
TABLE 161. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Drug Discovery Technologies market report include:

Abbott Laboratories, Inc.
Amgen Inc.
AstraZeneca PLC
Bayer Healthcare AG
Bio-Rad Laboratories, Inc.
bioMérieux SA
Bristol-Myers Squibb Company
Covaris, LLC
Curia Global, Inc.
Elucidata Corporation
Eurofins Advinus Private Limited
Evotec SE
F. Hoffmann-La Roche Ltd.
GE Healthcare Ltd.
Gilead Sciences, Inc.
Horiba, Ltd.
Illumina, Inc.
IQVIA Inc.
Luminex Corporation by DiaSorin Group
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
PIRAMAL PHARMA LIMITED
Randox Laboratories Ltd.
Revolution Medicines, Inc.
Sanofi S.A.
Sygnature Discovery Limited
Syngene International Limited
Thermo FIsher Scientific Inc.
VWR International LLC
WuXi AppTec Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	194
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 77.59 Billion
Forecasted Market Value ( USD ) by 2032	$ 145.8 Billion
Compound Annual Growth Rate	11.0%
Regions Covered	Global
No. of Companies Mentioned	32

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Drug Discovery Technologies Market

Scope & Segmentation

Key Takeaways: Strategic Insights for Senior Decision-Makers

Tariff Impact: Evolving Procurement and Supply Chain Strategies

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Drug Discovery Services Market Report 2025

Drug Discovery Technologies Market Report 2025

Drug Discovery Outsourcing Market - Global Forecast 2025-2032

Drug Discovery Services Market - Global Forecast 2025-2032

Drug Discovery Services - Company Evaluation Report, 2025